TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
07/07/2026
Back to search
Official data from USPTO
XTANDI SUPPORT SOLUTIONS (ENZALUTAMIDE) 40 MG CAPSULES
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
53
Latest update
07/09/2026
Trademark type
Combined
Nice classes
16
Filing date
02/03/2015
Registration date
04/19/2016
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
06/06/2026
Last transaction
07/09/2026
Responsible office
United States Patent and Trademark Office
Status code
800
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
2014-08-00
First use in commerce
2014-08-00
Drawing code
3
Owner type
16
Owner location
Northbrook, IL, US
Examiner
SAITO, KIM
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of the design of a curved band surrounded by three incomplete circles to the left of the stylized wording "XTANDI (ENZALUTAMIDE) 40 MG CAPSULES". Two vertical curved lines make up the letters "SS" next to the stylized wording "SUPPORT SOLUTIONS".
Holders and representatives
Holders
Astellas US LLC
Representatives
Christopher Bolinger Astellas
Technical classification
Nice Classes
Class 16
Vienna Codes
No Vienna codes available.
Goods and services
Class 16
Printed materialbrochuresbookletspostersfact sheets pertaining to prostate cancermedical conditionsmedical proceduresmedical treatmentsmedications and recovery
Publications
History of USPTO decisions and trademark events.
53 publications found
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
07/07/2026
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
07/07/2026
NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
06/06/2026
RNL1
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
06/06/2026
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
06/06/2026
PRAN
POST REGISTRATION ACTION MAILED NO RESPONSE REQUIRED
06/06/2026
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
06/06/2026
E89R
TEAS SECTION 8 & 9 RECEIVED
04/02/2026
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
04/19/2025
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
04/07/2025
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
04/07/2025
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
04/07/2025
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
04/07/2025
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
04/07/2025
EWAF
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
07/09/2024
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
07/09/2024
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
07/09/2024
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
07/09/2024
ASCK
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
07/04/2024
NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
10/17/2022
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
10/17/2022
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
10/12/2022
E815
TEAS SECTION 8 & 15 RECEIVED
04/15/2022
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
03/30/2022
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
03/30/2022
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
03/30/2022
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
04/19/2021
R.PR
REGISTERED-PRINCIPAL REGISTER
04/19/2016
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
03/18/2016
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
03/17/2016
SUPC
STATEMENT OF USE PROCESSING COMPLETE
03/17/2016
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
03/16/2016
IUAF
USE AMENDMENT FILED
02/10/2016
EISU
TEAS STATEMENT OF USE RECEIVED
02/10/2016
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
09/29/2015
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
08/04/2015
PUBO
PUBLISHED FOR OPPOSITION
08/04/2015
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
07/15/2015
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
06/26/2015
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
06/24/2015
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
06/23/2015
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
06/23/2015
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
06/23/2015
CEPE
COMBINED EXAMINER'S AMENDMENT/PRIORITY ACTION ENTERED
03/17/2015
ALIE
ASSIGNED TO LIE
03/16/2015
GEAN
NOTIFICATION OF EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED
03/16/2015
GEAP
EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED
03/16/2015
CPEA
EXAMINERS AMENDMENT AND/OR PRIORITY ACTION - COMPLETED
03/16/2015
DOCK
ASSIGNED TO EXAMINER
03/04/2015
MDSC
NOTICE OF DESIGN SEARCH CODE E-MAILED
02/13/2015
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
02/12/2015
NWAP
NEW APPLICATION ENTERED
02/06/2015
Continuous trademark protection
Get notified about every new filing that threatens XTANDI SUPPORT SOLUTIONS (ENZALUTAMIDE) 40 MG CAPSULES or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.